Exclusive

Publication

Byline

Clinical Trial: Exercise Programs in Women With PCOS

U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT07509762) titled 'Exercise Programs in Women With PCOS' on March 24. Brief Summary: This study aims to inves... Read More


Clinical Trial: Dynamic Postoperative Trends for Early Detection of Complications After Gastrointestinal Surgery

U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT07509710) titled 'Dynamic Postoperative Trends for Early Detection of Complications After Gastrointestinal Su... Read More


Clinical Trial: CGM After Discharge From Hospital

U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT07510386) titled 'CGM After Discharge From Hospital' on March 30. Brief Summary: This is an investigator ini... Read More


Clinical Trial: TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal Response

U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT07510191) titled 'TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal ... Read More


Maharashtra Seamless receives ESG score of 56

Mumbai, April 4 -- Maharashtra Seamless announced that NSE Sustainability Ratings and Analytics has assigned an Environmental, Social and Governance (ESG) score of "56" (Rating Category: Moderate) to ... Read More


नेक्सन, क्रेटा, अर्टिगा, पंच, वैगनआर, स्विफ्ट या बलेनो को छोड़, लोगों ने Rs.6.25 लाख की ये कार बनाई नंबर-1

नई दिल्ली, अप्रैल 4 -- मारुति डिजायर ने एक बार फिर अपनी कामयाबी का झंडा बुलंद कर दिया है। इस सेडान ने जहां फाइनेंशियल ईयर 2026 को देश की नंबर-1 कार के साथ खत्म किया। वहीं, मार्च 2026 में भी ये देश की ... Read More


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 4 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... Read More


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 4 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 4 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 4 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More